Will Obamacare rise from the ashes like the mythical phoenix? Here are three reasons to think the answer just might be "yes."
Medicaid enrollment has been the one bright spot for the Obamacare online exchanges. But those numbers might not be so bright after all.
Florida is a key state to measure the success of the Affordable Care Act. Here's what you should know about Obamacare in Florida.
What three investing lessons can we learn from Rockwell Medical's 70% climb over the past year? How does Rockwell relate to dialysis service providers DaVita Healthcare Partners and Fresenius Medical Care, as well as biotech giant Amgen?
Lots of numbers have been reported recently about Obamacare. Here are three that you've probably heard that don't really matter -- and one on which the fate of Obamacare hinges.
In the wake of UnitedHealth's announcement that Obamacare could take a bite out of its earnings next year, here are three big ways that Obamacare could make waves -- for better and for worse -- in the insurance industry in 2014
More Obamacare enrollment numbers are on their way soon. Will they be good, bad, or ugly? Here's what to expect.
Delay after delay ... after delay. Here's what all the Obamacare extensions and pushbacks mean for you.
For millions of Americans who'll rely on Obamacare, having enough young, healthy participants is essential. Find out why here.
Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?